Singapore, April 15 -- Swiss firm Galderma has announced the launch of Sculptra, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA) formulation, in China.This follows Sculptra's approval by China's National Medical Products Administration for correcting mid-facial volume loss and/or contour deficiencies last year.

Sculptra - which works with the body's natural processes to achieve healthier, radiant skin and a more youthful appearance - will now be available in China, where growth of aesthetics has outpaced the global market in the past decade.This launch is indicative of Galderma's commitment to expanding its unparalleled aesthetics portfolio into new geographies, in order to meet the needs of even m...